DA Davidson raised the firm’s price target on Ametek (AME) to $240 from $235 and keeps a Buy rating on the shares after meeting with its CEO. The firm has come away incrementally optimistic regarding the company’s organic growth and margin prospects heading into 2026, led by potential incremental strengthening in its Process and Power verticals, complimented by a resurgence of secularly-led growth within its medical and automation businesses alongside robust growth within A&D, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AME: